1. Home
  2. ATLO vs TLSI Comparison

ATLO vs TLSI Comparison

Compare ATLO & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ames National Corporation

ATLO

Ames National Corporation

N/A

Current Price

$32.46

Market Cap

287.3M

Sector

Finance

ML Signal

N/A

Logo TriSalus Life Sciences Inc.

TLSI

TriSalus Life Sciences Inc.

N/A

Current Price

$4.74

Market Cap

270.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ATLO
TLSI
Founded
1903
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
287.3M
270.2M
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
ATLO
TLSI
Price
$32.46
$4.74
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
29.0K
94.8K
Earning Date
04-24-2026
05-12-2026
Dividend Yield
3.43%
N/A
EPS Growth
8.03
N/A
EPS
0.38
N/A
Revenue
N/A
$45,151,000.00
Revenue This Year
N/A
$35.45
Revenue Next Year
N/A
$37.58
P/E Ratio
$85.50
N/A
Revenue Growth
N/A
53.41
52 Week Low
$19.56
$2.20
52 Week High
$32.62
$7.95

Technical Indicators

Market Signals
Indicator
ATLO
TLSI
Relative Strength Index (RSI) 61.15 45.47
Support Level $29.27 $4.70
Resistance Level N/A $4.82
Average True Range (ATR) 0.76 0.30
MACD 0.03 -0.07
Stochastic Oscillator 81.11 23.83

Price Performance

Historical Comparison
ATLO
TLSI

About ATLO Ames National Corporation

Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.

Share on Social Networks: